Innovative Research Award

Nazia Karsan is a British neurologist, clinical neuroscientist, and migraine researcher affiliated with King’s College London and multiple National Health Service institutions in the United Kingdom. Her research contributions have focused extensively on migraine pathophysiology, neuroimaging, trigeminovascular mechanisms, headache disorders, and translational neuroscience. She has contributed to advancing the understanding of migraine premonitory symptoms, neurovascular signaling, and functional imaging biomarkers in neurological disorders.[1]

Abstract

This academic article presents a scholarly overview of the clinical and scientific contributions of Nazia Karsan in the fields of neurology and migraine neuroscience. Her research has significantly contributed to the understanding of migraine pathophysiology, particularly the premonitory and postdrome phases of migraine attacks, neurovascular signaling, functional neuroimaging, and translational therapeutics. Through collaborative research with international headache experts and multidisciplinary neurological teams, Karsan has advanced evidence-based approaches to migraine diagnosis, neuroimaging interpretation, and targeted pharmacotherapy.[2]

Keywords

• Clinical Neuroscience
• Migraine Research
• Neurology
• Headache Disorders
• Functional Neuroimaging
• Premonitory Symptoms
• CGRP Therapeutics
• Translational Medicine
• Neurovascular Mechanisms

Introduction

Migraine remains one of the most prevalent neurological disorders worldwide, requiring continuous advancements in diagnostic precision, therapeutic development, and mechanistic understanding. Nazia Karsan has emerged as a leading contributor to this field through extensive clinical research, neuroimaging investigations, and translational neuroscience studies. Her academic career combines clinical neurology practice with high-impact headache research at King’s College London and associated healthcare institutions.[3]

Her scientific investigations have explored functional brain connectivity, migraine triggers, cranial autonomic symptoms, glutamatergic signaling, nitric oxide-mediated pathways, and pediatric migraine phenotyping. These contributions have provided deeper insight into migraine biology and the development of targeted therapeutic strategies.[4]

Research Profile

Karsan completed her MBBS with Merit in Clinical Practice at the Royal Free and University College Medical School in 2008 and earned a First Class Honours BSc in Neuroscience from University College London in 2006. She subsequently completed a PhD in Clinical Neuroscience at King’s College London in 2018, focusing on migraine mechanisms and neuroimaging research.[5]

She has held academic and clinical appointments including Consultant Neurologist at Lewisham and Greenwich NHS Trust, Honorary Consultant Adult Neurologist at Great Ormond Street Hospital for Children, and Postdoctoral Clinical Research Fellow within the Headache Group at King’s College London.[2]

Research Contributions

Karsan’s research contributions have centered on the neurobiological and vascular mechanisms involved in migraine pathogenesis. Her studies on calcitonin gene-related peptide (CGRP), acid-sensing ion channels, and nitric oxide signaling have supported the development of novel therapeutic strategies for migraine prevention and management.[4] Her neuroimaging investigations using functional magnetic resonance imaging and arterial spin labeling techniques have identified regional cerebral perfusion changes associated with migraine premonitory phases and triggered attacks. These findings have contributed to the broader understanding of migraine as a complex neurovascular disorder rather than solely a pain condition.[3]

Karsan has also contributed to pediatric headache medicine through studies examining migraine phenotyping in children and adolescents. Her work has highlighted the significance of early symptom recognition and non-painful manifestations in clinical diagnosis and management.[5]

Publications

• Karsan N and Goadsby PJ. Biological insights from premonitory symptoms of migraine. Nature Reviews Neurology, 2018.
• Karsan N and Goadsby PJ. Migraine: beyond pain. Practical Neurology, 2021.
• Karsan N and Goadsby PJ. New oral drugs for migraine. CNS Drugs, 2022.
• Karsan N et al. Regional cerebral perfusion during the premonitory phase of triggered migraine. Headache, 2023.
• Karsan N. Pathophysiology of migraine. Continuum, 2024.
• Karsan N and Goadsby PJ. Intervening in the Premonitory Phase to Prevent Migraine. CNS Drugs, 2024.
• Karsan N et al. Glutamate as a therapeutic substrate in migraine. International Journal of Medical Sciences, 2025.

Research Impact

Karsan’s work has received international recognition within neurology and headache medicine communities. Her research has been presented at the American Academy of Neurology, International Headache Society Congress, Migraine Trust International Symposium, and European Headache Congress.[1] She has received multiple awards including the International Headache Society Early Career Headache Science Award, American Headache Society Early Career Lecture Award, and Association of British Neurologists Top Poster distinctions. These recognitions reflect the scientific and translational significance of her contributions to clinical neuroscience.[1]

Award Suitability

Nazia Karsan demonstrates strong suitability for international recognition in clinical neuroscience and migraine research due to her sustained academic productivity, translational clinical investigations, interdisciplinary collaborations, and impact on headache medicine. Her work bridges laboratory neuroscience, neuroimaging, clinical neurology, and therapeutic innovation, contributing to improved understanding and management of migraine disorders.[2] Her contributions to migraine pathophysiology, pediatric neurology, and neurovascular signaling continue to influence both clinical practice and future research directions in headache medicine.[3]

Conclusion

Nazia Karsan has established an internationally recognized academic profile through her extensive contributions to neurology and migraine neuroscience. Her work has enhanced scientific understanding of migraine mechanisms, neuroimaging biomarkers, and therapeutic pathways while supporting advances in patient-centered headache management. Her multidisciplinary achievements demonstrate substantial merit for academic distinction and international research recognition.[4]

External Links

• Scopus Author Profile
  
• ORCID
• Google Scholar

References

1. Elsevier. (n.d.). Scopus author details: Dr Nazia Karsan, Author ID 55441531700. Scopus.
   https://www.scopus.com/authid/detail.uri?authorId=55441531700
   
2. Karsan N, Goadsby PJ. Biological insights from premonitory symptoms of migraine. Nature Reviews Neurology, 2018.
   https://doi.org/10.1038/s41582-018-0098-4
   
3. Karsan N and Goadsby PJ. Migraine: beyond pain. Practical Neurology, 2021.
4. Karsan N et al. Molecular mechanisms of migraine: nitric oxide, monoamines and vasoactive peptides. International Journal of Medical Sciences, 2023.
5. King’s College London. Clinical Neuroscience Research Profile of Dr Nazia Karsan.